Fundz

Who to call at Evotec, and when

Fundz watches for the moments Evotec starts buying, and tells you who to reach.

  • An alert the day Evotec raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evotec, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evotec. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Evotec receives $2.9m grant from Gates Foundation to enhance stem cell-based drug safety testing.

Nov 17, 2026

Contract Type

agreement

HamburgBiotechnologyHealth CarePharmaceutical

Description

Evotec has secured a $2.9m grant from the Gates Foundation to advance its stem cell-based New Approach Methodologies aimed at improving drug safety testing. This funding supports the continuation of a project that has already screened over 5000 compounds for developmental toxicity risks.

Quick answer

Evotec receives $2.9m grant from Gates Foundation to enhance stem cell-based drug safety testing. (November 17, 2026). Evotec is based in Hamburg, Hamburg, Germany.

What agreement did Evotec announce on November 17, 2026?
Evotec has secured a $2.9m grant from the Gates Foundation to advance its stem cell-based New Approach Methodologies aimed at improving drug safety testing. This funding supports the continuation of a project that has already screened over 5000 compounds for developmental toxicity risks.
What does Evotec do?
Evotec is a biotechnology company that is committed to advancing drug discovery and development.
Where is Evotec based?
Evotec is based in Hamburg, Hamburg, Germany.
Which similar companies announced agreements around the same time?
Pfizer (November 14, 2026), Sino Biopharmaceutical (November 13, 2026), Spektus Pharma (November 13, 2026) and Daiichi Sankyo Healthcare Co (November 10, 2026) also announced agreements within 45 days of Evotec.

Source: Fundz verified event record.

Other recent agreements in Pharmaceutical and Biotechnology

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

Evotec

Location

Hamburg, Hamburg, Germany

About

Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients.

Related People

Christian
Likely contact at this company
••••••••@••••••••

See Christian's verified email →

Joe
Senior decision-maker at this company
••••••••@••••••••

See Joe's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Evotec's next move

Learn about Strategic plan

Evotec signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.